{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:56:26Z","timestamp":1777647386316,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,15]]},"DOI":"10.7759\/cureus.88026","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T23:38:02Z","timestamp":1752622682000},"source":"Crossref","is-referenced-by-count":2,"title":["The Correlation of Optical Coherence Tomography Angiography Parameters With Serum Vascular Endothelial Growth Factor-A (VEGF-A) Levels in Diabetic Macular Edema"],"prefix":"10.7759","author":[{"given":"Punita K","family":"Sodhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aman S","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"D","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apoorva","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyani Hitenkumar","family":"Parvinbhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhawna","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bratati","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hage","family":"Amung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richa","family":"Asthana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Diabetic macular edema","author":"Taylor SC","year":"2018","unstructured":"Taylor SC, Montana C, Shah M, Apte RS. Diabetic macular edema. Retina Medical and Surgical Management. Kumar A  (ed): Jaypee Brothers, New Delhi, India; 2018. 1:309-330."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2016.03.010","article-title":"Vascular endothelial growth factor and diabetic macular edema","volume":"61","author":"Lally DR","year":"2016","unstructured":"Lally DR, Shah CP, Heier JS. Vascular endothelial growth factor and diabetic macular edema. Surv Ophthalmol. 2016, 61:759-68. 10.1016\/j.survophthal.2016.03.010","journal-title":"Surv Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/08977194.2018.1477140","article-title":"Evaluation of the growth factors VEGF-a and VEGF-B in the vitreous and serum of patients with macular and retinal vascular diseases","volume":"36","author":"Mesquita J","year":"2018","unstructured":"Mesquita J, Castro-de-Sousa JP, Vaz-Pereira S, Neves A, Passarinha LA, Tomaz CT. Evaluation of the growth factors VEGF-a and VEGF-B in the vitreous and serum of patients with macular and retinal vascular diseases. Growth Factors. 2018, 36:48-57. 10.1080\/08977194.2018.1477140","journal-title":"Growth Factors"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.61.2.26","article-title":"Correlation of aqueous, vitreous, and plasma cytokine levels in patients with proliferative diabetic retinopathy","volume":"61","author":"Wu F","year":"2020","unstructured":"Wu F, Phone A, Lamy R, et al.. Correlation of aqueous, vitreous, and plasma cytokine levels in patients with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2020, 61:26. 10.1167\/iovs.61.2.26","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/478509","article-title":"Correlation of vitreous vascular endothelial growth factor and uric acid concentration using optical coherence tomography in diabetic macular edema","volume":"2015","author":"Krizova L","year":"2015","unstructured":"Krizova L, Kalousova M, Kubena AA, Chrapek O, Chrapkova B, Sin M, Zima T. Correlation of vitreous vascular endothelial growth factor and uric acid concentration using optical coherence tomography in diabetic macular edema. J Ophthalmol. 2015, 2015:478509. 10.1155\/2015\/478509","journal-title":"J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6634637","article-title":"Optical coherence tomography angiography of macular perfusion changes after anti-VEGF therapy for diabetic macular edema: a systematic review","volume":"2021","author":"Elnahry AG","year":"2021","unstructured":"Elnahry AG, Elnahry GA. Optical coherence tomography angiography of macular perfusion changes after anti-VEGF therapy for diabetic macular edema: a systematic review. J Diabetes Res. 2021, 2021:6634637. 10.1155\/2021\/6634637","journal-title":"J Diabetes Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5814165","article-title":"Evaluation of changes in macular perfusion detected by optical coherence tomography angiography following 3 intravitreal monthly bevacizumab injections for diabetic macular edema in the IMPACT study","volume":"2020","author":"Elnahry AG","year":"2020","unstructured":"Elnahry AG, Abdel-Kader AA, Raafat KA, Elrakhawy K. Evaluation of changes in macular perfusion detected by optical coherence tomography angiography following 3 intravitreal monthly bevacizumab injections for diabetic macular edema in the IMPACT study. J Ophthalmol. 2020, 2020:5814165. 10.1155\/2020\/5814165","journal-title":"J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701920","article-title":"Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy","volume":"20","author":"Lee IG","year":"2006","unstructured":"Lee IG, Chae SL, Kim JC. Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy. Eye (Lond). 2006, 20:546-52. 10.1038\/sj.eye.6701920","journal-title":"Eye (Lond)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050794","article-title":"Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy","volume":"40","author":"Burgos R","year":"1997","unstructured":"Burgos R, Sim\u00f3 R, Aud\u00ed L, Mateo C, Mesa J, Garc\u00eda-Ram\u00edrez M, Carrascosa A. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy. Diabetologia. 1997, 40:1107-9. 10.1007\/s001250050794","journal-title":"Diabetologia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.3.311","article-title":"Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy","volume":"86","author":"Funatsu H","year":"2002","unstructured":"Funatsu H, Yamashita H, Nakanishi Y, Hori S. Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. Br J Ophthalmol. 2002, 86:311-5. 10.1136\/bjo.86.3.311","journal-title":"Br J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003554","article-title":"Endogenous VEGF is required for visual function: evidence for a survival role on m\u00fcller cells and photoreceptors","volume":"3","author":"Saint-Geniez M","year":"2008","unstructured":"Saint-Geniez M, Maharaj AS, Walshe TE, et al.. Endogenous VEGF is required for visual function: evidence for a survival role on m\u00fcller cells and photoreceptors. PLoS One. 2008, 3:e3554. 10.1371\/journal.pone.0003554","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/biom11070988","article-title":"VEGF as a direct functional regulator of photoreceptors and contributing factor to diabetes-induced alteration of photoreceptor function","volume":"11","author":"Hu J","year":"2021","unstructured":"Hu J, Zhu M, Li D, Wu Q, Le YZ. VEGF as a direct functional regulator of photoreceptors and contributing factor to diabetes-induced alteration of photoreceptor function. Biomolecules. 2021, 11:14-6. 10.3390\/biom11070988","journal-title":"Biomolecules"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10098","article-title":"Expression and role of VEGF-A in the ciliary body","volume":"53","author":"Ford KM","year":"2012","unstructured":"Ford KM, Saint-Geniez M, Walshe TE, D'Amore PA. Expression and role of VEGF-A in the ciliary body. Invest Ophthalmol Vis Sci. 2012, 53:7520-7. 10.1167\/iovs.12-10098","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161332","article-title":"Vascular endothelial growth factor-a increases the aqueous humor outflow facility","volume":"11","author":"Fujimoto T","year":"2016","unstructured":"Fujimoto T, Inoue T, Maki K, Inoue-Mochita M, Tanihara H. Vascular endothelial growth factor-a increases the aqueous humor outflow facility. PLoS One. 2016, 11:e0161332. 10.1371\/journal.pone.0161332","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-019-1143-9","article-title":"Comparison of subfoveal choroidal thickness in eyes with CRVO and BRVO","volume":"19","author":"Tang F","year":"2019","unstructured":"Tang F, Xu F, Zhong H, et al.. Comparison of subfoveal choroidal thickness in eyes with CRVO and BRVO. BMC Ophthalmol. 2019, 19:133. 10.1186\/s12886-019-1143-9","journal-title":"BMC Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e31820f4b39","article-title":"Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy","volume":"31","author":"Maruko I","year":"2011","unstructured":"Maruko I, Iida T, Sugano Y, Ojima A, Sekiryu T. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Retina. 2011, 31:1603-8. 10.1097\/IAE.0b013e31820f4b39","journal-title":"Retina"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2002","article-title":"Ocular anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy","volume":"37","author":"Sim\u00f3 R","year":"2014","unstructured":"Sim\u00f3 R, Sundstrom JM, Antonetti DA. Ocular anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy. Diabetes Care. 2014, 37:893-9. 10.2337\/dc13-2002","journal-title":"Diabetes Care"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.07.014","article-title":"VEGF-induced blood flow increase causes vascular hyper-permeability in vivo","volume":"464","author":"Ashina K","year":"2015","unstructured":"Ashina K, Tsubosaka Y, Kobayashi K, Omori K, Murata T. VEGF-induced blood flow increase causes vascular hyper-permeability in vivo. Biochem Biophys Res Commun. 2015, 464:590-5. 10.1016\/j.bbrc.2015.07.014","journal-title":"Biochem Biophys Res Commun"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210167","article-title":"The role of diabetic choroidopathy in the pathogenesis and progression of diabetic retinopathy","volume":"24","author":"Scuderi L","year":"2023","unstructured":"Scuderi L, Fragiotta S, Di Pippo M, Abdolrahimzadeh S. The role of diabetic choroidopathy in the pathogenesis and progression of diabetic retinopathy. Int J Mol Sci. 2023, 24:16-8. 10.3390\/ijms241210167","journal-title":"Int J Mol Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello LP","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG, et al.. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994, 331:1480-7. 10.1056\/NEJM199412013312203","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/385282-the-correlation-of-optical-coherence-tomography-angiography-parameters-with-serum-vascular-endothelial-growth-factor-a-vegf-a-levels-in-diabetic-macular-edema","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T23:38:04Z","timestamp":1752622684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/385282-the-correlation-of-optical-coherence-tomography-angiography-parameters-with-serum-vascular-endothelial-growth-factor-a-vegf-a-levels-in-diabetic-macular-edema"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.88026","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,15]]}}}